GW Pharmaceuticals PLC (NASDAQ:GWPH)

131.01
Delayed Data
As of Feb 16
 +0.34 / +0.26%
Today’s Change
92.65
Today|||52-Week Range
143.37
-0.76%
Year-to-Date
No recent news for GW Pharmaceuticals PLC.

Today’s Trading

Previous close130.67
Today’s open130.58
Day’s range129.78 - 131.30
Volume205,098
Average volume (3 months)371,341
Market cap$3.6B
Data as of 3:59pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)-65.46%
Earnings growth (this year)-23.83%
Earnings growth (next 5 years)-50.35%
Revenue growth (last year)-28.45%
P/E ratioNM
Price/Sales246.06
Price/Book8.90

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...-0.04-0.03%
PBHPrestige Brands Hold...+0.39+1.12%
MDCOMedicines Co+0.82+2.54%
ICPTIntercept Pharmaceut...+0.52+0.86%
Data as of 4:15pm ET, 02/16/2018

Financials

Last reporting dateFebruary 5, 2018
EPS forecast (this quarter)-$2.08
Annual revenue (last year)$10.4M
Annual profit (last year)-$166.8M
Net profit margin-1,598.54%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Justin D. Gover
Chief Operating Officer
Christopher John Tovey
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts